Approximately two weeks after becoming a public-listed company for the second time history, denim firm Levi Strauss (NYSE: LEVI) is coming up with its first quarter 2019 earnings results on April 9, Tuesday, before the regular trading hours.
The company, which had offered its shares at $17 apiece at the IPO on March 21, saw its shares close higher at $22.41 at the end of the first day. The stock is currently trading at $21.78, over 28% higher than the IPO price.
In fiscal 2018, the San Francisco-based firm’s revenue increased 14% year-over-year to $5.6 billion on a reported basis. Net income for the year was flat at $285 million.
When Levi Strauss reported its fourth quarter and full-year 2018 results in early February, CEO Chip Bergh had said: “It’s clear our strategies to diversify our product portfolio, expand our direct-to-consumer business, and deepen our connection with consumers worldwide have worked, resulting in both higher annual revenues and gross margins.”
When the company reports its first-quarter results on Tuesday, investors will be looking at year-over-year growth in revenue and net income. During the year-ago quarter (Q1 2018), Levi Strauss had reported a 22% increase in net revenue to $1.34 billion. Adjusted net income almost doubled to $117 million.
READ: LYFT AND SIX OTHER COMPANIES WENT PUBLIC IN MARCH. FULL LIST
Investors will be looking forward to the earnings conference call where the management is expected to give a blueprint of how it plans to use the IPO proceeds. At the time of the IPO filing, The company had said proceeds would be used for general corporate purposes, including working capital, operating expenses and capital expenditures.
It also indicated that it may use a portion of net proceeds for acquisitions or other strategic investments.
Listen to on-demand earnings calls and hear how management responds to analysts’ questions
Most Popular
United Parcel Service (UPS) seems on track to regain lost strength
Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic
IPO Alert: What to look for when Boundless Bio goes public
Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.
Nike (NKE) bets on innovation and partnerships to return to high growth
Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company
Comments